Breaking News, Collaborations & Alliances

Kindeva, Rocket Science Health Create New Intranasal Delivery Platform

Together, they will find partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal platform used for precisely targeting specific regions of the nasal cavity.

By: Rachel Klemovitch

Assistant Editor

Kindeva, a global CDMO, and Rocket Science Health (RSH), a Canadian technology healthcare company, are looking to find partners to develop a new intranasal delivery platform.  The non-exclusive agreement will see Kindeva and RSH identify partners for the development of the ‘RSH Olfactory Delivery Device,’ a dual nostril intranasal platform used for precisely targeting specific regions of the nasal cavity.  The device can deposit most of a drug dose into the Olfactory Clefts. Olfactory...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters